Bristol-Myers Squibb Company PFD CONV 2
USD400.00
-540.22 (-57.46%)
CEO
Christopher S. Boerner
IPO Date
2003-12-08
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTC
Country
US
Open
$780.50
Prev. Close
$940.22
Day Low
$400.00
Day High
$780.50
52W Low
$400.00
52W High
$1050.00
Market Cap
$814.59B
Volume
0.00M
| -12.8 |
| 31 Dec 2023 | FY | 56.3% | 17.8% | 27.3% | 8.4% | 1.41 | 1.43 | 13.2 |
| 31 Dec 2022 | FY | 57.4% | 13.7% | 20.4% | 6.5% | 1.31 | 1.25 | 24.2 |
| 31 Dec 2021 | FY | 57.7% | 15.1% | 19.5% | 6.4% | 1.27 | 1.52 | 19.8 |
| 31 Dec 2020 | FY | 51.0% | -21.2% | -23.8% | -7.6% | 1.37 | 1.58 | -15.6 |
| 31 Dec 2019 | FY | 66.0% | 13.2% | 6.7% | 2.6% | 0.92 | 1.60 | 31.8 |
| 31 Dec 2018 | FY | 71.3% | 21.8% | 35.1% | 14.1% | 0.52 | 1.66 | 17.3 |
| 31 Dec 2017 | FY | 72.0% | 4.8% | 8.6% | 3.0% | 0.68 | 1.55 | 100.1 |
| 31 Dec 2016 | FY | 74.6% | 22.9% | 27.6% | 13.2% | 0.41 | 1.55 | 21.9 |
| 25.3 |
| 30 Sept 2025 | Q3 | 71.9% | 18.0% | 11.9% | 2.3% | 2.75 | 1.27 | 10.4 |
| 30 Jun 2025 | Q2 | 65.8% | 10.7% | 7.5% | 1.4% | 2.92 | 1.21 | 18.0 |
| 31 Mar 2025 | Q1 | 65.5% | 21.9% | 14.1% | 2.7% | 2.95 | 1.28 | 12.6 |
| 31 Dec 2024 | Q4 | 60.2% | 0.6% | 0.4% | 0.1% | 3.13 | 1.25 | 398.5 |
| 30 Sept 2024 | Q3 | 55.6% | 10.2% | 7.1% | 1.3% | 3.00 | 1.24 | 21.7 |
| 30 Jun 2024 | Q2 | 55.7% | 13.8% | 9.9% | 1.8% | 3.17 | 1.16 | 12.5 |
| 31 Mar 2024 | Q1 | 55.5% | -100.4% | -72.2% | -12.0% | 3.48 | 1.11 | -2.2 |
| 31 Dec 2023 | Q4 | 56.6% | 15.4% | 6.0% | 1.9% | 1.41 | 1.43 | 14.8 |